Chopra H K
Indian Heart J. 2009 Mar-Apr;61(2):138-45.
Diastolic Heart failure (DHF) is the major cause of morbidity and mortality all over the world. It is responsible for more than 50% of the heart failure cases. New onset of symptomatic DHF is a lethal disease with a 5-yr mortality of approximately 50%. DHF is also referred to as heart failure (HF) with normal left ventricular ejection fraction (LVEF)-HFNLVEF. The diagnosis of DHF requires the following criteria: (i) signs and symptoms of heart failure (ii) normal or mildly abnormal systolic left ventricular (LV) function (iii) evidence of LV diastolic dysfunction. Diagnostic evidence of LV diastolic dysfunction can be obtained invasively (LV end-diastolic pressure > 16 mmHg or mean pulmonary capillary wedge pressure > 12 mmHg) or non-invasively by tissue Doppler imaging (TDI) (E/E' > 15). If TDI yields an E/E' ratio suggestive of LV diastolic dysfunction (15 > E/E' > 8), then additional echo variables are required for diagnostic evidence of LV diastolic dysfunction, which include Doppler flow profile of mitral valve or pulmonary veins, measurement of LV mass index (LVMi) or left atrium volume index (LAVi), electrocardiographic evidence of atrial fibrillation or high levels of B-natreuretic peptide. Echo-Doppler techniques using LV filling pressures and tissue Doppler imaging of the mitral annulus help in identifying and classifying the degree of LV diastolic dysfunction. However, clinically this is more relevant to advanced overt disease. Therefore early recognition of DHF in relatively asymptomatic or less symptomatic patients with occult LV diastolic dysfunction is a real challenge. Recently it has been shown that reduction in left atrial strain and strain rate and increase in left atrial (LA) stiffness index has a high predictive value for detection of occult LV diastolic dysfunction. Thus early recognition of occult DHF and timely therapeutic intervention may help in prognostic stratification in DHF.
舒张性心力衰竭(DHF)是全球发病和死亡的主要原因。它占心力衰竭病例的50%以上。新发生的有症状DHF是一种致命疾病,5年死亡率约为50%。DHF也被称为左心室射血分数正常的心力衰竭(HF)-HFNLVEF。DHF的诊断需要以下标准:(i)心力衰竭的体征和症状;(ii)收缩期左心室(LV)功能正常或轻度异常;(iii)LV舒张功能障碍的证据。LV舒张功能障碍的诊断证据可通过侵入性方法获得(LV舒张末期压力>16 mmHg或平均肺毛细血管楔压>12 mmHg),或通过组织多普勒成像(TDI)非侵入性获得(E/E'>15)。如果TDI得出的E/E'比值提示LV舒张功能障碍(15>E/E'>8),则需要额外的超声心动图变量来作为LV舒张功能障碍的诊断证据,这些变量包括二尖瓣或肺静脉的多普勒血流频谱、LV质量指数(LVMi)或左心房容积指数(LAVi)的测量、心房颤动的心电图证据或高水平的B型利钠肽。使用LV充盈压和二尖瓣环组织多普勒成像的超声多普勒技术有助于识别和分类LV舒张功能障碍的程度。然而,在临床上,这与晚期显性疾病更相关。因此,在相对无症状或症状较轻但存在隐匿性LV舒张功能障碍的患者中早期识别DHF是一项真正的挑战。最近有研究表明,左心房应变和应变率降低以及左心房(LA)僵硬度指数增加对隐匿性LV舒张功能障碍的检测具有较高的预测价值。因此,早期识别隐匿性DHF并及时进行治疗干预可能有助于DHF的预后分层。